Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07769489 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Assess Tolerability of Injecting Larger Volumes (2-5 mL) Subcutaneously at Different Rates: Participant Experience and Acceptance

Name: Study to Assess Tolerability of Injecting Larger Volumes (2-5 mL) Subcutaneously at Different Rates: Participant Experience and Acceptance — clinical trial record (NCT07769489)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RISE

StatusNot Yet Recruiting

PhasePhase 1

SponsorNovo Nordisk A/S

Started2026-08-17

View on ClinicalTrials.gov ↗

The purpose of the study is to investigate the tolerability of different injection/infusion volumes and speed compared to standard practise. The order in which the different volumes and injection speeds will be given to participants will be allocated by chance. Participants will be in this clinical study for about 1 week.

Trial Details

NCT Number	NCT07769489
Lead Sponsor	Novo Nordisk A/S
Conditions	Healthy Participants
Enrollment	100 participants
Start Date	2026-08-17
Primary Completion	2026-12-09 (estimated)
Study Completion	2026-12-11 (estimated)
Updated on ClinicalTrials.gov	2026-08-18